ResearcherNorthwestern UniversityActive in the last 2 years

Chengwei Peng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4381-0268; OpenAlex author ID A5102662157. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2025: 2 papers

Papers 2

Emerging Therapeutic Approaches to Pancreatic Adenocarcinoma: Advances and Future Directions. Co-author DOI 10.1007/s11864-025-01352-2 ↗
Ultra-sensitive detection of mutant KRAS in circulating tumor DNA predicts survival in resectable pancreatic adenocarcinoma. Co-author DOI 10.3389/fonc.2025.1657746 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Paul E. Oberstein · 1 shared paper, 2025 · strength 0.54
- Paper Emerging Therapeutic Approaches to Pancreatic Adenocarcinoma: Advances and Future Directions. DOI 10.1007/s11864-025-01352-2 ↗
Dominic J. Vitello · 1 shared paper, 2025 · strength 0.23
- Paper Ultra-sensitive detection of mutant KRAS in circulating tumor DNA predicts survival in resectable pancreatic adenocarci… DOI 10.3389/fonc.2025.1657746 ↗
M.C. Cox · 1 shared paper, 2025 · strength 0.23
- Paper Ultra-sensitive detection of mutant KRAS in circulating tumor DNA predicts survival in resectable pancreatic adenocarci… DOI 10.3389/fonc.2025.1657746 ↗
Akhil Chawla · 1 shared paper, 2025 · strength 0.23
- Paper Ultra-sensitive detection of mutant KRAS in circulating tumor DNA predicts survival in resectable pancreatic adenocarci… DOI 10.3389/fonc.2025.1657746 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.